Cyclophosphamide, rituximab tied to less permanent organ damage in older polyangiitis patients
Immunosuppressive treatment with cyclophosphamide and rituximab in elderly patients with microscopic polyangiitis (MPA) and granulomatosis with polyangiitis (GPA) is not associated with hospitalization and may result in the development of less permanent organ damage, reveals a study.
Cyclophosphamide, rituximab tied to less permanent organ damage in older polyangiitis patients
16 Apr 2020
